Sheetal Patel is a Counsel with several years of experience litigating chemical, biotech, and pharmaceutical patent cases as well as developing enforcement strategies including invalidity and infringement analyses, and due diligence.  Ms. Patel’s litigation experience includes U.S. district court, International Trade Commission, and appellate litigation, with particular experience related to the Hatch-Waxman Act governing the approval of pharmaceutical drugs.  Ms. Patel has broad experience in all aspects of litigation, including patent litigation strategy development, claim construction, managing complex fact discovery, working with expert and fact witnesses, conducting and defending fact and expert depositions, drafting pretrial and post-trial briefing, and trial preparation.

Ms. Patel also counsels a diverse mix of companies ranging from start-ups to large global corporations regarding intellectual property, strategic collaborations, agreements, commercialization, investments, and licensing.  Prior to practicing law, Ms. Patel performed research and development at a global Fortune 100 company as well as a start-up biotechnology company.

REPRESENTATIVE EXPERIENCE

  • Asserted patents in complex litigations related to the Hatch-Waxman Act governing the approval of pharmaceutical drugs (ANDA), including matters involving branded drugs Strattera®, Abilify®, and Protopic®.
  • Defended Chinese chemical manufacturer of pesticides against a large manufacturer’s patent assertions at the International Trade Commission. 

PREVIOUS EXPERIENCE

  • Finnegan, Henderson, Farabow, Garrett, and Dunner LLP, Associate
  • Centocor Inc. – Johnson & Johnson, Assistant Engineer

PRO BONO AND COMMUNITY INVOLVEMENT

Ms. Patel devotes a portion of her time to pro bono matters. She has successfully represented a number of parents seeking custody in civil cases in the Superior Court of the District of Columbia.

MEMBERSHIPS AND AFFILIATIONS

  • South Asian Bar Association
  • ChIPs – Women in IP
  • Network of South Asian Professionals

PUBLICATIONS AND SPEECHES

  • “Overt Mistake and the Presumption of Validity: Questions and Insights After Sciele Pharma v. Lupin Ltd.,” Westlaw Journal Intellectual Property (Oct. 4, 2012).
  • “Patent Term Adjustments,” American Chemical Society, Middle Atlantic Regional Meeting, Wilmington, DE (2010).
  • “Safe Harbor – Recent developments in 271(e)(1),” American Chemical Society National Meeting & Exposition, Indianapolis (2013).
  • Patent Litigation Mock Trial, Global Intellectual Property Convention, Mumbai, India (2014).

LANGUAGES

  • Hindi
  • Gujarati

Education

  • Seton Hall University School of Law, J.D., 2009
    Seton Hall Circuit Review Journal
  • Rutgers University, School of Engineering, B.S., Chemical Engineering, 2003

Admissions

Texas

District of Columbia

U.S. Patent and Trademark Office